Business Description
Remed Co Ltd
ISIN : KR7302550009
Share Class Description:
XKRX:302550: Ordinary SharesCompare
Compare
Traded in other countries / regions
302550.Korea IPO Date
2018-08-14Description
Remed Co Ltd is a Korean medical equipment manufacturing company. The company is engaged in researching and developing products to treat brain disorders such as depression, anxiety, stroke and Parkin's. It has developed TMS device and is manufacturing pain therapy devices using advanced electromagnetic stimulation, shockwave (RSWT) and laser technologies. Its products offerings include Transcranial Magnetic simulator for brain, Electromagnetic simulators including Salus Talent, Salus Talent A, Salus Talent Pro, and Optimus Pro for pain therapy; and Rosetta, Salus RSWT and Optimus Pro as a part of Extracorporeal Shockwave Therapy. It also offers Electrosurgical units from REMED including ELPIS 4L, ELPIS 4, ELPIS 3, and ELPIS2.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.18 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.38 | |||||
| Debt-to-EBITDA | 4.19 | |||||
| Interest Coverage | 0.41 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 3.58 | |||||
| Beneish M-Score | -2.37 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.9 | |||||
| 3-Year EPS without NRI Growth Rate | 4.5 | |||||
| 3-Year Book Growth Rate | 7.3 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.92 | |||||
| 9-Day RSI | 47.54 | |||||
| 14-Day RSI | 49.35 | |||||
| 6-1 Month Momentum % | 29.33 | |||||
| 12-1 Month Momentum % | 16.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.82 | |||||
| Quick Ratio | 1.44 | |||||
| Cash Ratio | 0.95 | |||||
| Days Inventory | 194.55 | |||||
| Days Sales Outstanding | 79.93 | |||||
| Days Payable | 29.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.2 | |||||
| Shareholder Yield % | 1.49 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.22 | |||||
| Operating Margin % | 1.94 | |||||
| Net Margin % | 20.76 | |||||
| FCF Margin % | 24.54 | |||||
| ROE % | 14.81 | |||||
| ROA % | 8 | |||||
| ROIC % | 0.78 | |||||
| ROC (Joel Greenblatt) % | 6.85 | |||||
| ROCE % | 5.21 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 24.87 | |||||
| PE Ratio without NRI | 25.53 | |||||
| Price-to-Owner-Earnings | 306.68 | |||||
| PS Ratio | 4.88 | |||||
| PB Ratio | 3.03 | |||||
| Price-to-Tangible-Book | 3.19 | |||||
| Price-to-Free-Cash-Flow | 20.75 | |||||
| Price-to-Operating-Cash-Flow | 18.15 | |||||
| EV-to-EBIT | 50.76 | |||||
| EV-to-EBITDA | 32.72 | |||||
| EV-to-Revenue | 4.8 | |||||
| EV-to-FCF | 19.65 | |||||
| Price-to-Graham-Number | 1.9 | |||||
| Price-to-Net-Current-Asset-Value | 22.41 | |||||
| Earnings Yield (Greenblatt) % | 1.97 | |||||
| FCF Yield % | 4.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Remed Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 23,423.028 | ||
| EPS (TTM) (â‚©) | 151.57 | ||
| Beta | 1.09 | ||
| Volatility % | 39.2 | ||
| 14-Day RSI | 49.35 | ||
| 14-Day ATR (â‚©) | 199.270206 | ||
| 20-Day SMA (â‚©) | 3819.25 | ||
| 12-1 Month Momentum % | 16.17 | ||
| 52-Week Range (â‚©) | 2545 - 4420 | ||
| Shares Outstanding (Mil) | 30.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Remed Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Remed Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Remed Co Ltd Frequently Asked Questions
What is Remed Co Ltd(XKRX:302550)'s stock price today?
The current price of XKRX:302550 is â‚©3770.00. The 52 week high of XKRX:302550 is â‚©4420.00 and 52 week low is â‚©2545.00.
When is next earnings date of Remed Co Ltd(XKRX:302550)?
The next earnings date of Remed Co Ltd(XKRX:302550) is .
Does Remed Co Ltd(XKRX:302550) pay dividends? If so, how much?
Remed Co Ltd(XKRX:302550) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers